O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+12.32%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$5.22B
AUM Growth
+$5.22B
(+97,106%)
Cap. Flow
+$35.6M
Cap. Flow
% of AUM
0.68%
Top 10 Holdings %
Top 10 Hldgs %
34.68%
Holding
137
New
7
Increased
25
Reduced
21
Closed
21
Top Buys
| 1 |
UnitedHealth
UNH
|
$60.1M |
| 2 |
Ionis Pharmaceuticals
IONS
|
$46.3M |
| 3 |
Tenet Healthcare
THC
|
$28.2M |
| 4 |
Vaxcyte
PCVX
|
$27.1M |
| 5 |
Evolent Health
EVH
|
$23.3M |
Top Sells
| 1 |
argenx
ARGX
|
$96M |
| 2 |
Disc Medicine
IRON
|
$72.9M |
| 3 |
Pfizer
PFE
|
$61.8M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$29.4M |
| 5 |
VRNA
Verona Pharma
VRNA
|
$29.3M |
Sector Composition
| 1 | Healthcare | 98.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Pfizer
PFE
$141B
| $71.4M | 1.37% | 1,393,600 -1,205,400 | -46% | -$61.8M |
|
27
Adicet Bio
ACET
$59.9M
| $66.6M | 1.27% | 7,447,140 | – | – |
|
28
Edwards Lifesciences
EW
$47.8B
| $64.2M | 1.23% | 860,500 -105,800 | -11% | -$7.89M |
|
|
29
Vaxcyte
PCVX
$4B
| $61.5M | 1.18% | 1,283,126 +565,226 | +79% | +$27.1M |
|
|
VECT
30
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
| $60.7M | 1.16% | 7,006,861 +533,300 | +8% | +$4.62M |
|
31
Prelude Therapeutics
PRLD
$68.5M
| $60.6M | 1.16% | 10,039,691 | – | – |
|
|
32
Tenet Healthcare
THC
$16.3B
| $59.5M | 1.14% | 1,220,300 +577,000 | +90% | +$28.2M |
|
33
Crinetics Pharmaceuticals
CRNX
$2.92B
| $58.5M | 1.12% | 3,196,876 | – | – |
|
|
MRTX
34
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $58.2M | 1.11% | 1,283,692 -135,200 | -10% | -$6.13M |
|
35
PMV Pharmaceuticals
PMVP
$74.2M
| $57.1M | 1.09% | 6,563,077 | – | – |
|
|
KDNY
36
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $53.2M | 1.02% | 2,029,300 | – | – |
|
37
Mersana Therapeutics
MRSN
$36.5M
| $52.8M | 1.01% | 9,011,437 | – | – |
|
38
Syndax Pharmaceuticals
SNDX
$1.41B
| $51.1M | 0.98% | 2,006,500 | – | – |
|
39
Repare Therapeutics
RPTX
$71.7M
| $48.9M | 0.93% | 3,322,488 | – | – |
|
40
Xtant Medical Holdings
XTNT
$83.3M
| $48.3M | 0.92% | 73,114,592 | – | – |
|
41
89bio
ETNB
$1.34B
| $46.6M | 0.89% | 3,658,869 | – | – |
|
42
SI-BONE Inc
SIBN
$719M
| $45.8M | 0.88% | 3,368,000 | – | – |
|
43
Xenon Pharmaceuticals
XENE
$2.98B
| $45.3M | 0.87% | 1,149,100 +11,800 | +1% | +$465K |
|
44
Aclaris Therapeutics
ACRS
$209M
| $43.4M | 0.83% | 2,758,434 | – | – |
|
|
45
Disc Medicine
IRON
$2.07B
| $43M | 0.82% | 2,160,941 -3,665,282 | -63% | -$72.9M |
|
46
AbCellera Biologics
ABCL
$1.25B
| $42.4M | 0.81% | 4,180,768 | – | – |
|
47
scPharmaceuticals
SCPH
$295M
| $39.9M | 0.76% | 5,559,528 +762,380 | +16% | +$5.47M |
|
48
uniQure
QURE
$896M
| $39.6M | 0.76% | 1,747,555 +150,555 | +9% | +$3.41M |
|
|
BLU
49
DELISTED
BELLUS Health Inc.
BLU
| $38.7M | 0.74% | 4,708,900 +74,000 | +2% | +$608K |
|
50
Janux Therapeutics
JANX
$1.37B
| $37.4M | 0.71% | 2,836,386 | – | – |
|